Skip to main content

Table 2 Clinical and surgical characteristics of patients after 1:1 exact matching by size and stage of tumor

From: Recurrence after thymoma resection according to the extent of the resection

Variables

Extended thymectomy

Limited thymectomy

P value

(n = 86)

(n = 86)

Age, mean ± SD

45.3 ± 12.14

49.7 ± 13.60

0.027

Sex

  

0.284

  Male

43 (50.0)

51 (59.3)

 

  Female

43 (50.0

35 (40.7)

 

MG

  

< 0.0001

  No

22 (25.6)

76 (88.4)

 

  Yes

64 (74.4)

10 (11.6)a

 

WHO histologic type

  

0.001

  A

6 (7.0)

12 (14.0)

 

  AB

15 (17.4)

34 (39.5)

 

  B1

20 (23.3)

12 (14.0)

 

  B2

17 (19.8)

17 (19.8)

 

  B3

28 (32.6)

11 (12.8)

 

Operative approach

  

< 0.0001

  Median sternotomy

61 (70.9)

8 (9.3)

 

  Thoracotomy

8 (9.3)

27 (31.4)

 

  VATS

16 (18.6)

47 (54.7)

 

  Clamshell

1 (1.2)

-

 

  Cervicotomy

-

2 (2.3)

 

  Robotic

-

2 (2.3)

 

Tumor size, mean ± SD

6.4 ± 2.67

6.4 ± 2.67

0.943

Masaoka –Koga stage

  

>0.999

  I

51 (59.3)

51 (59.3)

 

  IIa + IIb

31 (36.1)

31 (36.1)

 

  III

4 (4.6)

4 (4.6)

 

  IVa + IVb

-

-

 

Adjuvant therapy

  

0.069

  None

50 (58.1)

64 (74.4)

 

  Radiotherapy

30 (34.9)

21 (24.4)

 

  Chemotherary

2 (2.3)

0 (0.0)

 

  Chemoradiation

4 (4.7)

1 (1.2)

 

Follow-up time, mean ± SD

94.5 ± 65.35

85.6 ± 67.92

0.386

Pattern of recurrence

   

  Local

0

1

 

  Local + regional

0

2

 

  Regional

3

7

 

  Distant

2

0

 
  1. apost-thymectomy myasthenia gravis.